The validation of a test method is the process by which the relevance and reliability of the method are assessed for a particular purpose. It is an essential stage in the evolution of the method from its development to its acceptance and application for regulatory purposes. The principles according to which alternative tests should be validated have been agreed upon at an international level, although the actual process by which the validation process is conducted varies between different validation authorities. This paper summarises the principles of alternative test development and validation and describes how the principles have been applied to the validation of in vitro tests by the European Centre for the Validation of Alternative Methods (ECVAM).
Anon. (1991). Establishment of a European Centre for the Validation of Alternative Methods (ECVAM). Communication from the Commission to the Council and the European Parliament, 29 October 1991. SEC(91) 1794 final, 6 pp. Brussels, Belgium: European Commission.
2.
RussellW.M.S., & BurchR.L. (1959). The Principles of Humane Experimental Technique, 238 pp. London, UK: Methuen.
3.
WorthA.P., & BallsM. eds (2002). Alternative (non-animal) methods for chemicals testing: current status and future prospects. A report prepared by ECVAM and the ECVAM Working Group on Chemicals. ATLA30, Suppl. 1, 1–125.
4.
ArcherG., BallsM., BrunerL.H., CurrenR.D., FentemJ.H., HolzhütterH-G., LiebschM., LovellD.P., & SoutheeJ.A. (1997). The validation of toxicological prediction models. ATLA25, 505–516.
5.
BrunerL.H., CarrG.J., ChamberlainM., & CurrenR.D. (1996). Validation of alternative methods for toxicity testing. Toxicology in Vitro10, 479–501.
6.
BrunerL., CarrG., ChamberlainM., & CurrenR. (1996). No prediction model, no validation study. ATLA24, 139–142.
7.
ArcherG. (1996). No statistics, no science — let alone validation studies. ATLA24, 453–456.
8.
HolzhütterH-G., & SpielmannH. (1996). The use of prediction models in toxicology: what should they predict?ATLA24, 881–884.
9.
WorthA.P., & BallsM. (2001). The importance of the prediction model in the development and validation of alternative tests. ATLA29, 135–143.
10.
GenschowE., ScholzG., BrownN.A., PiersmaA.H., BradyM., ClemannN., HuuskonenH., PaillardF., BremerS., & SpielmannH. (2000). Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study. In Vitro & Molecular Toxicology13, 51–65.
11.
SpielmannH., LiebschM., KalweitS., MoldenhauerF., WirnsbergerT., HolzhütterH-G., SchneiderB., GlaserS., GernerI., PapeW.J.W., KreilingR., KrauserK., MiltenburgerH.G., SteilingW., LuepkeN.P., MullerN., KreuzerH., MurmannP., SpenglerJ., Bertram-NeisE., SiegemundB., & WiebelF.J. (1996). Results of a validation study in Germany on two in vitro alternatives to the Draize eye irritation test, the HET-CAM test and the 3T3-NRU cytotoxicity test. ATLA24, 741–858.
12.
WorthA.P., & CroninM.T.D. (2001). Prediction models for eye irritation potential based on endpoints of the HETCAM and neutral red uptake tests. In Vitro & Molecular Toxicology14, 143–156.
13.
BallsM., BlaauboerB., BrusickD., FrazierJ., LambD., PembertonM., ReinhardtC., RoberfroidM., RosenkranzH., SchmidB., SpielmannH., StammatiA-L., & WalumE. (1990). Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures. ATLA18, 313–337.
14.
HolzhütterH-G., ArcherG., DamiN., LovellD.P., SaltelliA., & SjöströmM. (1996). Recommendations for the application of biostatistical methods during the development and validation of alternative toxicological methods. ECVAM Biostatistics Task Force Report 1. ATLA24, 511–530.
15.
BallsM., BlaauboerB.J., FentemJ.H., BrunerL., CombesR.D., EkwallB., FielderR.J., GuillouzoA., LewisR.W., LovellD.P., ReinhardtC.A., RepettoG., SladowskiD., SpielmannH., & ZuccoF. (1995). Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM workshop 5. ATLA23, 129–147.
16.
FentemJ.H., & BallsM. (1997). The ECVAM approach to validation. In Animal Alternatives, Welfare and Ethics. Proceedings of the 2nd World Congress on Alternatives and Animal Use in the Life Sciences, Utrecht, The Netherlands, 20–24 October 1996 — Developments in Animal and Veterinary Sciences, Volume 27 (ed. van ZutphenL.F.M., & BallsM.), pp. 1083–1089. Amsterdam, The Netherlands: Elsevier Science B.V.
17.
WorthA.P., & BallsM. (2001). The role of ECVAM in promoting the regulatory acceptance of alternative methods in the European Union. ATLA29, 525–535.
18.
BallsM., & KarcherW. (1995). The validation of alternative test methods. ATLA23, 884–886.
19.
BallsM., & FentemJ.H. (1997). Progress toward the validation of alternative tests. ATLA25, 33–43.
20.
Cooper-HannanR., HarbellJ.W., CoeckeS., BallsM., BoweG., CervinkaM., ClothierR., HermannF., KlahmL.K., de LangeJ., LiebschM., & VanparysP. (1999). The principles of good laboratory practice: application to in vitro toxicology studies. The report and recommendations of ECVAM workshop 37. ATLA27, 539–577.
21.
BallsM., & FentemJ.H. (1999). The validation and acceptance of alternatives to animal testing. Toxicology in Vitro13, 837–846.
22.
NIH (1997). Validation and Regulatory Acceptance of Toxicological Test Methods. A Report of the ad hoc Interagency Coordinating Committee on the Validation of Alternative Methods. NIH Publication 97-3981, 105 pp. Research Triangle Park, NC, USA: NIEHS.
23.
NIH (1999). Evaluation of the Validation Status of Toxicological Methods: General Guidelines for Submissions to ICCVAM (Revised, October 1999). NIH Publication 99-4496, 44 pp. Research Triangle Park, NC, USA: NIEHS.
24.
OECD (1996). Final Report of the OECD Workshop on Harmonization of Validation and Acceptance Criteria for Alternative Toxicological Test Methods, 60 pp. Paris, France: OECD.
25.
CurrenR.D., SoutheeJ.A., SpielmannH., LiebschM., FentemJ.H., & BallsM. (1995). The role of prevalidation in the development, validation and acceptance of alternative methods. ATLA23, 211–217.
26.
BallsM. (1997). Defined structural and performance criteria would facilitate the validation and acceptance of alternative test procedures. ATLA25, 483–484.
27.
LiebschM., TraueD., BarrabasC., SpielmannH., UphillP., WilkinsS., McPhersonJ.P., WiemannC., KaufmannT., RemmeleM., & HolzhütterH-G. (2000). The ECVAM prevalidation study on the use of EpiDerm for skin corrosivity testing. ATLA28, 371–401.
28.
BarrattM.D., BrantomP.G., FentemJ.H., GernerI., WalkerA.P., & WorthA.P. (1998). The ECVAM international validation study on in vitro tests for skin corrosivity. 1. Selection and distribution of the test chemicals. Toxicology in Vitro12, 471–482.
29.
FentemJ.H., ArcherG.E.B., BallsM., BothamP.A., CurrenR.D., EarlL.K., EsdaileD.J., HolzhütterH-G., & LiebschM. (1998). The ECVAM international validation study on in vitro tests for skin corrosivity. 2. Results and evaluation by the management team. Toxicology in Vitro12, 483–524.
30.
HalderM., HendriksenC., CusslerK., & BallsM. (2002). ECVAM's contributions to the implementation of the Three Rs in the production and quality control of biologicals. ATLA30, 93–108.
31.
ECVAM (1998). Statement on the scientific validity of the 3T3 NRU PT test (an in vitro test for phototoxic potential). ATLA26, 7–8.
32.
SpielmannH., BallsM., DupuisJ., PapeW.J., PechovitchG., de SilvaO., HolzhütterH-G., ClothierR., DesolleP., GerberickF., LiebschM., LovellW.W., MaurerT., PfannenbeckerU., PotthastJ.M., CsatoM., SladowskiD., SteilingW., & BrantomP. (1998). The international EU/COLIPA in vitro phototoxicity validation study: results of phase II (blind trial). Part 1: The 3T3 NRU phototoxicity test. Toxicology in Vitro12, 305–327.
33.
ECVAM (1998). Statement on the scientific validity of the rat skin transcutaneous electrical resistance (TER) test (an in vitro test for skin corrosivity). ATLA26, 275–277.
34.
ECVAM (1998). Statement on the scientific validity of the EPISKIN™ test (an in vitro test for skin corrosivity). ATLA26, 277–280.
35.
BothamP.A., ChamberlainM., BarrattM.D., CurrenR.D., EsdaileD.J., GardnerJ.R., GordonV.C., HildebrandB., LewisR.W., LiebschM., LogemannP., OsborneR., PonecM., RégnierJ.F., SteilingW., WalkerA.P., & BallsM. (1995). A prevalidation study on in vitro skin corrosivity testing. The report and recommendations of ECVAM workshop 6. ATLA23, 219–255.
36.
ECVAM (1998). Statement on the application of the 3T3 NRU PT test to UV filter chemicals. ATLA26, 385–386.
37.
SpielmannH., BallsM., DupuisJ., PapeW.J.W., de SilvaO., HölzhutterH-G., GerberickF., LiebschM., LovellW.W., & PfannenbeckerU. (1998). A study on the phototoxic potential of UV filter chemicals from Annex VII of European Union Directive 76/768/EEC, in the in vitro 3T3 NRU phototoxicity test. ATLA26, 679–708.
38.
ECVAM (2000). Statement on on the validity of the local lymph node assay for skin sensitisation testing. ATLA28, 366–367.
39.
NIH (1999). The murine local lymph node assay.The Results of an Independent Peer Review Evaluation Coordinated by the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and the National Toxicology Program Center for the Evaluation of Alternative Toxicological Methods (NICEATM). NIH Publication no. 99-4494, 211 pp. Research Triangle Park, NC, USA: NIEHS.
40.
ECVAM (2000). Statement on the application of the Epiderm™ human skin model for skin corrosivity testing. ATLA28, 365–367.
41.
ECVAM (2001). Statement on the application of the CORROSITEX® assay for skin corrosivity testing. ATLA29, 96–97.
42.
NIH (1999). Corrositex®: an In Vitro Test Method for Assessing Dermal Corrosivity Potential of Chemicals. NIH Publication No. 99-4495. Research Triangle Park, NC, USA: NIEHS.
43.
ECVAM (2002). Statement on the scientific validity of the embryonic stem cell test (EST) — an in vitro test for embryotoxicity. ATLA30, 265–268.
44.
ECVAM (2002). Statement on the scientific validity of the postimplantation rat whole-embryo culture assay — an in vitro test for embryotoxicity. ATLA30, 271–273.
45.
ECVAM (2002). Statement on the scientific validity of the micromass test — an in vitro test for embryotoxicity. ATLA30, 268–270.
46.
BrownN.A. (2002). Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. ATLA30, 177–198.
47.
GenschowG., SpielmannH., ScholzG., SeilerA., BrownN.A., PiersmaA.H., BradyM., ClemannN., HuuskonenH., PaillardF., BremerS., & BeckerK. (2002). The ECVAM international validation study on in vitro embryotoxicity tests. Results of the definitive phase and evaluation of prediction models. ATLA30, 151–176.
48.
HalderM., BallsM., HendriksenC., & CusslerK. (2004). ECVAM's activities in promoting the Three Rs in the quality control of biologicals. ATLA32, Suppl. 1, 93–98.
